Protalix BioTherapeutics to Delist its Common Stock from the

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...

Related Keywords

United States , Israel , Brazil , Carmiel , Ha Afon , Israeli , American , Dror Bashan , Chiesi Farmaceutici , Chuck Padala , Protalix Biotherapeutics Inc , Holders Of The Company , Drug Administration , Aviv Stock Exchange , Exchange Commission , Prnewswire Protalix Biotherapeutics Inc , Pfizer Inc , Trading Of The Company , Company Common Stock , Common Stock , Chief Executive , Private Securities Litigation Reform Act ,